1
|
Domínguez-López A, Magaña-Guerrero FS, Buentello-Volante B, Vivanco-Rojas Ó, Garfias Y. NFAT5: a stress-related transcription factor with multiple functions in health and disease. Cell Stress 2025; 9:16-48. [PMID: 40421201 PMCID: PMC12105643 DOI: 10.15698/cst2025.05.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2024] [Revised: 04/06/2025] [Accepted: 04/23/2025] [Indexed: 05/28/2025] Open
Abstract
Nuclear factor of activated T cells 5 (NFAT5) is a transcription factor within the Rel family, primarily recognized for its role in cellular adaptation to osmotic stress, particularly in hypertonic and hyperosmotic environments. Beyond osmotic regulation, NFAT5 responds to diverse stimuli, including cytokines, growth factors, oxidative stress, and microbial signals. This versatility enables NFAT5 to regulate essential cellular processes such as proliferation, survival, migration, and vascular remodelling. In the immune system, NFAT5 modulates the function of monocytes, macrophages, astrocytes, microglia, and T cells, contributing to immune homeostasis and inflammatory responses. Dysregulation of NFAT5 activity is implicated in various pathological conditions, including autoimmune diseases, cancer, and cardiovascular disorders, largely due to its ability to control genes involved in inflammatory and immune pathways under both isotonic and hypertonic conditions. Recent studies have unveiled new regulatory mechanisms, including interactions with non-coding RNAs, offering deeper insights into the functional landscape of NFAT5 and its therapeutic potential. This review delves into the multifaceted roles of NFAT5 in health and disease, emphasizing its emerging importance as a promising therapeutic target.
Collapse
Affiliation(s)
- Alfredo Domínguez-López
- Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México. Mexico City, Mexico. 04510
- Cell and Tissue Biology Department, Research Unit, Institute of Ophthalmology Conde de Valenciana. Mexico City, Mexico. 06800
| | - Fátima S. Magaña-Guerrero
- Cell and Tissue Biology Department, Research Unit, Institute of Ophthalmology Conde de Valenciana. Mexico City, Mexico. 06800
| | - Beatriz Buentello-Volante
- Cell and Tissue Biology Department, Research Unit, Institute of Ophthalmology Conde de Valenciana. Mexico City, Mexico. 06800
| | - Óscar Vivanco-Rojas
- Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México. Mexico City, Mexico. 04510
- Cell and Tissue Biology Department, Research Unit, Institute of Ophthalmology Conde de Valenciana. Mexico City, Mexico. 06800
| | - Yonathan Garfias
- Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autónoma de México. Mexico City, Mexico. 04510
- Cell and Tissue Biology Department, Research Unit, Institute of Ophthalmology Conde de Valenciana. Mexico City, Mexico. 06800
| |
Collapse
|
2
|
Ertürk E, Işık Ü, Aktepe E. Analysis of blood sodium level in autism spectrum disorder. INTERNATIONAL JOURNAL OF DEVELOPMENTAL DISABILITIES 2023; 70:1520-1523. [PMID: 39713519 PMCID: PMC11660411 DOI: 10.1080/20473869.2023.2197309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 03/15/2023] [Accepted: 03/27/2023] [Indexed: 12/24/2024]
Abstract
Introduction A number of recent studies have brought attention to the involvement of dietary salt and blood sodium levels in the etiopathogenesis of autism. In our study, by comparing the blood sodium levels of children with autism spectrum disease (ASD) and healthy children, we aimed to shed light on the etiopathogenesis of ASD. Method We retrospectively analyzed the blood sodium levels obtained from the 4-year follow-up of 84 children (42 with ASD and 42 controls). Results According to the comparison of blood sodium levels obtained from the 4-year follow-up of children in the ASD and control groups, no significant difference was found between the blood sodium levels of both groups. Discussion The notion that blood sodium levels influence the progression of autism is novel, and the majority of material on this topic comes from animal trials. The results of the few human-focused studies are controversial. More studies are needed to elucidate the role of blood sodium levels and salt consumption in the etiology of autism.
Collapse
Affiliation(s)
- Emre Ertürk
- Department of Child and Adolescent Psychiatry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey
| | - Ümit Işık
- Department of Child and Adolescent Psychiatry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey
| | - Evrim Aktepe
- Department of Child and Adolescent Psychiatry, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey
| |
Collapse
|
3
|
Thawley AJ, Veneziani LP, Rabelo-da-Ponte FD, Riederer I, Mendes-da-Cruz DA, Bambini-Junior V. Aberrant IL-17 Levels in Rodent Models of Autism Spectrum Disorder: A Systematic Review. Front Immunol 2022; 13:874064. [PMID: 35757754 PMCID: PMC9226456 DOI: 10.3389/fimmu.2022.874064] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2022] [Accepted: 05/04/2022] [Indexed: 12/09/2022] Open
Abstract
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder characterised by stereotyped behaviours, specific interests, and impaired communication skills. Elevated levels of pro-inflammatory cytokines, such as interleukin-17A (IL-17A or IL-17), have been implicated as part of immune alterations that may contribute to this outcome. In this context, rodent models have helped elucidate the role of T-cell activation and IL-17 secretion in the pathogenesis of ASD. Regarding the preclinical findings, the data available is contradictory in offspring but not in the pregnant dams, pointing to IL-17 as one of the main drivers of altered behaviour in some models ASD, whilst there are no alterations described in IL-17 levels in others. To address this gap in the literature, a systematic review of altered IL-17 levels in rodent models of ASD was conducted. In total, 28 studies that explored IL-17 levels were included and observed that this cytokine was generally increased among the different models of ASD. The data compiled in this review can help the choice of animal models to study the role of cytokines in the development of ASD, seeking a parallel with immune alterations observed in individuals with this condition.
Collapse
Affiliation(s)
- Alexandra Jade Thawley
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom
| | - Luciana Peixoto Veneziani
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom.,Laboratory on Thymus Research, Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.,National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.,Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
| | - Francisco Diego Rabelo-da-Ponte
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom.,Laboratory of Molecular Psychiatry, Centro de Pesquisa Experimental (CPE) and Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre (RS), Brazil
| | - Ingo Riederer
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom.,Laboratory on Thymus Research, Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.,National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.,Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
| | - Daniella Areas Mendes-da-Cruz
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom.,Laboratory on Thymus Research, Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.,National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.,Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
| | - Victorio Bambini-Junior
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, United Kingdom.,National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.,Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom
| |
Collapse
|